RebeccaLOlinMD

PubMed

• Phase 1 dose escalation study of the MDM2 inhibitor milademetan as monotherapy and in combination with azacitidine in patients with myeloid malignancies.
  Courtney D DiNardo, Rebecca Olin, Eunice S Wang, Barry Skikne, Joseph Rosenthal
  Cancer Medicine. 2024-07-01
• 2 citations
  Venetoclax and Cobimetinib in Relapsed/Refractory AML: A Phase 1b Trial.
  Marina Y Konopleva, Monique Dail, Naval G Daver, Jacqueline S Garcia, Brian A Jonas
  Clinical Lymphoma, Myeloma & Leukemia. 2024-06-01
• 7 citations
  A study to assess the efficacy of enasidenib and risk-adapted addition of azacitidine in newly diagnosed IDH2-mutant AML.
  Sheng F Cai, Ying Huang, Jennie R Lance, Hsiaoyin Charlene Mao, Andrew J Dunbar
  Blood Advances. 2024-01-23

Abstracts/Posters

• Incidence of Serious Adverse Events, Pneumonitis, Infection and Sepsis in Patients with Relapsed and Refractory Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphom...
  Rebecca L. Olin, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• A Phase 1 Dose Escalation Study of Milademetan in Combination with 5-Azacitidine (AZA) in Patients with Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndr...
  Rebecca Olin, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Direct Oral Anticoagulant Use and Outcomes in Patients with High and Intermediate Risk BCR-ABL-Negative Myeloproliferative Neoplasms
  Rebecca L. Olin, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Precision Medicine Treatment in Older AML: Results of Beat AML Master TrialClinically Relevant Abstract
  Rebecca L. Olin, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Join now to see all

Lectures

• Friday Scientific Workshop on Hematology and Aging: From Bleeding Disorders to Malignant Hematology 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Cognitive Impairment Is Associated with Inferior Survival and Increased Non-Relapse Mortality in Older Allogeneic Hematopoietic Cell Transplant (alloHCT) Recipients: A... 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Aging and Hematologic Disorders: Exploring the Evidence 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Junior Faculty Career-Development Session 
  60th American Society of Hematology Annual Meeting - 12/1/2018
• Hematology & Aging: Scientific Advances From Sickle Cell Disease to Malignant Hematology 
  60th American Society of Hematology Annual Meeting - 11/30/2018
• Join now to see all